KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Prepaid Assets (2017 - 2025)

Amneal Pharmaceuticals (AMRX) has 7 years of Prepaid Assets data on record, last reported at $82.7 million in Q4 2023.

  • For Q4 2023, Prepaid Assets fell 20.16% year-over-year to $82.7 million; the TTM value through Dec 2023 reached $82.7 million, down 20.16%, while the annual FY2023 figure was $82.7 million, 20.16% down from the prior year.
  • Prepaid Assets reached $82.7 million in Q4 2023 per AMRX's latest filing, down from $103.6 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $121.4 million in Q1 2022 and bottomed at $3.2 million in Q1 2020.
  • Average Prepaid Assets over 5 years is $82.5 million, with a median of $79.9 million recorded in 2019.
  • Peak YoY movement for Prepaid Assets: plummeted 97.13% in 2020, then soared 2248.03% in 2021.
  • A 5-year view of Prepaid Assets shows it stood at $66.7 million in 2019, then increased by 10.15% to $73.5 million in 2020, then surged by 50.02% to $110.2 million in 2021, then decreased by 6.04% to $103.6 million in 2022, then fell by 20.16% to $82.7 million in 2023.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $82.7 million in Q4 2023, $103.6 million in Q4 2022, and $121.4 million in Q1 2022.